Patent Face-Off: FDA Denial Isn’t The End Of Rapid-Exchange Dispute
This article was originally published in The Gray Sheet
Executive Summary
FDA has denied a citizen petition seeking to derail Abbott's efforts to extend its rapid-exchange delivery patent for the Xience V drug-eluting stent, but the petitioner says that was all according to plan